Skip to main content
Premium Trial:

Request an Annual Quote

Quest Diagnostics Gets FDA Emergency Use Authorization for COVID-19 Sample Collection Kit

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for a SARS-CoV-2 molecular testing sample collection kit from Quest Diagnostics.

The Quest COVID-19 Nucleic Acid Test Collection Kit is designed for the self-collection of anterior nasal swab specimens for use with tests that detect SARS-CoV-2 nucleic acid. The kit includes specimen collection and storage materials, as well as instructions for returning the kit to a drop-off location, according to the FDA.

Secaucus, New Jersey-based Quest has received EUAs from the FDA for a number of COVID-19 testing products including three direct-to-consumer tests and accompanying home sample collection kit about a year ago.

The company said last month that its COVID-19 testing revenues were down 75 percent year over year in 2022 and are expected to be down between 81 and 88 percent year over year in 2023.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.